主页文献库搜索
KRAS-Driven Combined Pulmonary Adenocarcinoma and Atypical Carcinoid Tumor: A...

Banerjee(AB),Thomas-Ogunniyi(J),Narula(N),... Ann Clin Lab Sci 2026-05-00

...KRAS p.G12S mutations and high PD-L1 expression. A 74-year-old woman with a remote history of stage IV colon cancer pres...

Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue...

Zeinhom(A),Mohamed(AY),Abdel-Aziz(NN),Saye... Stem Cell Rev Rep 2026-08-00

...KRAS, MMP9, RUNX2) were identified as contributors to insulin resistance-related pathways and were used to construct a m...

KRAS4A promotes oligomerization of hexokinase 1 on mitochondria.

Nuevo-Tapioles(C),Qin(Z),Bazley(A),Branco(... Cell Rep 2026-06-23

...KRAS upregulates glycolysis in cancer is direct interaction of KRAS4A with hexokinase 1 (HK1), but the mechanism is unkn...

Pigmented Birthmarks and Spinal Neurofibromas in KRAS Mosaicism-Not to Be Con...

Forde(KM),Knöpfel(N),Loebel(U),Kinsler(VA) Pediatr Dermatol 2026-00-00

We report a child presenting with pigmentary skin lesions and spinal neurofibromas who was diagnosed molecularly with KR...

NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.

Jeong(J),Hausmann(S),Dong(H),Szczepski(K),... Nature 2026-01-00

...KRASG12C-driven pancreatic and lung tumours in mouse models to a comparable level as KRAS inhibition with sotorasib6. In...

Predominant Serrated Molecular Signature in Postcolonoscopy Colorectal Cancer...

Yeh(JH),Moi(SH),Chen(CC),Hsu(CW),Yeh(WS),T... Am J Gastroenterol 2026-01-01

...KRAS mutations (OR 0.63, 95% CI 0.45-0.87). Furthermore, MSI was strongly correlated with BRAF mutation (OR 9.36, 95% CI...

Histopathologic and molecular evidence of malignant potential in morules asso...

Agostini-Vulaj(D),Oltavi(ZN),Liao(X) Virchows Arch 2026-04-00

...KRAS as the most common mutated gene in five of seven (71%) tested cases, followed by PIK3CA (43%) and APC (29%). The mo...

Inflammatory Rhabdomyoblastic Tumor: A Clinicopathological and Immunohistoche...

Yang(Y),Yuan(J),Zhu(P),Wang(J) Appl Immunohistochem Mol Mo... 2026-09-15

...KRAS (n=1) genes among the tested cases. With a median follow-up of 17.5 months (range: 3 to 77 mo) in 22 patients, 2 ca...

Case Report: Remarkable response to savolitinib plus chemotherapy and bevaciz...

Huang(Y),Shu(P),Gu(S),Wen(F),Wang(X) Front Oncol 2026-00-00

...KRAS/NRAS/BRAF wild-type descending colon cancer with liver metastases and de novo MET amplification detected in the pre...

Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors ...

Ai(X),Song(Z),Wu(L),Zhou(A),Cheng(D),Zong(... Nat Med 2026-09-00

...KRASG12D proteins, in a phase 1 dose-escalation trial in patients with advanced solid tumors harboring the KRASG12D muta...

上一页 21 22 23 24 25 26 27 28 29 下一页 25 / 共 953

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]